For decades, breast cancer survivors going through menopause have been told that hormone therapy is off-limits—full stop. But new analyses and a 2025 expert consensus paper suggest that there may be ...
While hormone replacement therapy (HRT) is not broadly linked to young-onset breast cancer, using certain types before menopause could increase the risk of it developing in young women, a new study ...
The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research. Recent changes to the warning labels on hormone ...
HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...
Using some types of HRT before the menopause could increase the risk of breast cancer in young women, a study suggests. The research found that overall the use of hormone replacement therapy (HRT) was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results